PROTAGENIC THERAPEUTICS INC (PTIX) Stock Cash Flow
USA - NASDAQ:PTIX - US74365N3017 - Common Stock
4.08 USD
-0.21 (-4.9%)
| TTM (2025-6-30) | 2025 (2024-12-31) | 2024 (2023-12-31) | 2023 (2022-12-31) | 2022 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.17M | -5.53M | -5.00M | -3.56M | -4.52M | |||
| Depreciation Amortization | 100.00 | 50.30K | 28.20K | 0.00 | 0.00 | |||
| Change In Working Capital | 852.70K | 467.50K | -114.40K | 540.00K | -140.00K | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 3.29M | 791.00K | 1.38M | 1.02M | 1.86M | |||
| OPERATING CASH FLOW | 975.80K | -4.22M | -3.70M | -1.99M | -2.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -149.80K | 0.00 | 0.00 | |||
| Other Investing Activity | N/A | 2.80M | 4.93M | 1.60M | -9.91M | |||
| INVESTING CASH FLOW | N/A | 2.80M | 4.78M | 1.60M | -9.91M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 1.81M | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 4.40M | 1.96M | 1.96M | 0.00 | 12.58M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 4.48M | 1.96M | 1.96M | 0.00 | 12.58M | |||
| Exchange Rate Effect | -117.60K | 700.00 | 1.00K | 70.00K | 0.00 | |||
| CHANGE IN CASH | 3.48M | 550.60K | 1.07M | -320.00K | -130.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 975.80K | -4.22M | -3.70M | -1.99M | -2.80M | |||
| Capital Expenditure | N/A | 0.00 | -149.80K | 0.00 | 0.00 | |||
| FREE CASH FLOW | 975.80K | -4.22M | -3.85M | -1.99M | -2.80M | |||
All data in USD